Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation

European Journal of Human Genetics

Volumn 12, Issue 3, 2004, Pages 187-191

  Faisel, Fareeza ^a,b   Romppanen, Eeva Liisa ^b   Hiltunen, Mikko ^b   Helisalmi, Seppo ^b   Laasanen, Jaana ^a   Punnonen, Kari ^b   Salonen, Jukka T ^b   Heinonen, Seppo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Association study; Factor V; Polymorphism; Pre eclampsia; Pregnancy

Indexed keywords

ADENINE; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; GUANINE; TYROSINE;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXON; FEMALE; FINLAND; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ARGININE; FACTOR V; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYSINE; MUTATION; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY;

EID: 4444253955     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201124     Document Type: Article

References (22)

1. Dahlback B, Hansson C, Islam MQ et al: Assignment of gene for coagulation factor V to chromosome 1 in man and to chromosome 13 in rat. Somat Cell Mol Genet 1988; 14: 509-514.
2. Kane WH, Davie EW: Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 1988; 71: 539-555.
3. Dahlback B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008.
4. Bertina RM, Koeleman BP, Koster T et al: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
5. Zoller B, Svensson PJ, He X, Dahlback B: Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-2524.
6. Graf LL, Welsh CH, Qamar Z, Marlar RA: Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden. Am J Clin Pathol 2003; 119: 52-60.
7. Hiyoshi M, Arnutti P, Prayoonwiwat W et al: A polymorphism nt 1628G->A (R485K) in exon 10 of the coagulation factor V gene may be a risk factor for thrombosis in the indigenous Thai population. Thromb Haemost 1998; 80: 705-706.
8. Le W, Yu JD, Lu L et al: Association of the R485K polymorphism of the factor V gene with poor response to activated protein C and increased risk of coronary artery disease in the Chinese population. Clin Genet 2000; 57: 296-303.
9. Rey E, Kahn SR, David M, Shrier I: Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003; 361: 901-908.
10. Spina V, Aleandri V, Morini F: The impact of the factor V Leiden mutation on pregnancy. Hum Reprod Update 2000; 6: 301-306.
11. van Pampus MG, Dekker GA, Wolf H et al: High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol 1999; 180: 1146-1150.
12. Watanade H, Hamada H, Yamada N et al: Association analysis of nine missense polymorphisms in the coagulation factor V gene with severe preeclampsia in pregnant Japanese women. J Hum Genet 2002; 47: 131-135.
13. Peltonen L, Jalanko A, Varilo T: Molecular genetics of the Finnish disease heritage. Hum Mol Genet 1999; 8: 1913-1923.
14. National High Blood Pressure Working Group: Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
15. Arngrimsson R, Björnsson H, Geirsson R: Analysis of different inheritance patterns in preeclampsia/eclampsia syndrome. HypertensPregnancy 1995; 14: 27-38.
16. Grandone E, Margaglione M, Colaizzo D et al: Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997; 77: 1052-1054.
17. Dizon-Townson DS, Nelson LM, Easton K, Ward K: The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996; 175: 902-905.
18. Lindoff C, Ingemarsson I, Martinsson G, Segelmark M, Thysell H, Astedt B: Preeclampsia is associated with a reduced response to activated protein C. Am J Obstet Gynecol 1997; 176: 457-460.
19. Rigo Jr J, Nagy B, Fintor L et al: Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregnancy 2000; 19: 163-172.
20. Pastinen T, Perola M, Ignatius J et al: Dissecting a population genome for targeted screening of disease mutations. Hum Mol Genet 2001; 10: 2961-2972.
21. Gandrille S, Greengard JS, Alhenc-Gelas M et al: Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM. Blood 1995; 86: 219-224.
22. Helley D, Besmond C, Ducrocq R et al: Polymorphism in exon 10 of the human coagulation factor V gene in a population at risk for sickle cell disease. Hum Genet 1997; 100: 245-248.